Offerings // Niagen Bioscience, Inc.

NAGE offering history

Every offering-related filing in Niagen Bioscience, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 977 filings back to Jan 18, 2007.

Last executed offering

Jul 10, 2026

424B5 — priced deal (shares or notes)

Last registration (announced)

Jun 29, 2026

S-3 — capacity, not a sale

Executed, last 12 months

424B pricings + 8-K 3.02 sales

Registered, last 12 months

S-1/S-3/F-series registrations

Date	Filing		What it means
Jul 10, 2026	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jul 9, 2026	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Jun 29, 2026	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Nov 21, 2024	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Jul 6, 2023	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jul 5, 2023	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Jun 22, 2023	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Nov 17, 2022	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Nov 16, 2022	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Nov 3, 2022	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Oct 11, 2022	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Apr 22, 2021	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Apr 22, 2021	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Mar 23, 2021	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Feb 25, 2021	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Jun 26, 2020	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jun 26, 2020	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Jun 12, 2020	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Jun 3, 2020	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Jun 1, 2020	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
May 21, 2020	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
May 7, 2020	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Oct 2, 2019	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Oct 2, 2019	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Sep 26, 2019	S-3/A →	REGISTERED	S-3/A registration — capacity to sell shares, not a sale yet
Sep 12, 2019	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Aug 15, 2019	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
May 20, 2019	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Jan 3, 2018	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Dec 29, 2017	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Dec 14, 2017	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Nov 21, 2017	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Nov 9, 2017	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Nov 8, 2017	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Oct 31, 2017	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Aug 21, 2017	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Jun 21, 2017	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Jun 21, 2017	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Jun 9, 2017	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
May 25, 2017	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)

NAGE offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full NAGE workspace →

NAGE offering FAQ

When did NAGE last execute an offering?

Per SEC filings, Niagen Bioscience, Inc.'s most recent priced offering document is a 424B5 filed 2026-07-10. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did NAGE last announce or register an offering?

The most recent registration is a S-3 filed 2026-06-29. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.